Biocompatibility Innovation
Biocompatibility Innovation (BCI) is an Italy-based, privately held company founded in 2014 that develops technologies and products to enhance the biocompatibility of biological and polymeric implantable medical devices, serving medical device manufacturers and implant developers.
- Company typePrivate
- Founded2014
- HeadquartersEste, Italy
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Biocompatibility Innovation does
Biocompatibility Innovation (BCI) is a privately held Italian company founded in 2014 and headquartered in Este, Italy, that develops technologies and products intended to enhance the biocompatibility of biological and polymeric implantable medical devices. The company's stated mission centers on materials and surface-engineering solutions that improve the interaction between implants and host tissue, addressing a regulated niche in the broader medical device supply chain where ISO 10993, FDA, and EU MDR requirements govern market entry.
The company operates with a very small team (stated headcount of 1–10) and has raised a single disclosed funding round of approximately $5,471,657 in July 2014, with participation from EISMEA — the EU's SME Executive Agency that administers instruments such as the SME Instrument — and Fondazione Golinelli, an Italian science-focused foundation. Alessandro Gandaglia is listed as Chief Executive Officer. The public-facing website (bci-biocompatibility.com) currently presents only a loading/verification page and does not expose product details, pricing, customer references, certifications, or technical specifications, so the operating model, revenue mechanics, and commercialization status cannot be substantively verified from the available data.
Biocompatibility Innovation firmographics
Firmographics- Name
- Biocompatibility Innovation
- Website
- https://bci-biocompatibility.com
- Company type
- Private
- Founded year
- 2014
- Headcount range
- 1–10 employees
- Short description
- Biocompatibility Innovation (BCI) is an Italy-based, privately held company founded in 2014 that develops technologies and products to enhance the biocompatibility of biological and polymeric implantable medical devices, serving medical device manufacturers and implant developers.
- Ownership category
- akta.pro rank
Biocompatibility Innovation industry classification
Industry- Product category
- Medical Device Biocompatibility Technologies
- NAICS
- Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113), Plastics Material and Resin Manufacturing (325211)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Plastic Materials, Synth Resins & Nonvulcan Elastomers (2821), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Biodegradable Medical & Hygiene Materials (absorbables, disposables substrates) (IMAEAOAL)
- akta.pro secondary industries
- Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH), Bio-based & Biodegradable Polymer Resin Manufacturing (PLA, PHA, PBS, starch blends) (IMANAAAG)
Keywords
Where Biocompatibility Innovation is headquartered
LocationHeadquarters
- HQ city
- Este
- HQ country
- Italy
- HQ region
- Europe
Markets served
Biocompatibility Innovation business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Biocompatibility Innovation product offering
Product offeringCore offering
Biocompatibility Innovation develops technologies and products that improve the biocompatibility of biological and polymeric implantable medical devices. The company focuses on material and surface-level innovations that help medical device manufacturers achieve safer, more compatible implants for clinical use.
Differentiator
Problem solved
Functional benefit
Products and services
- Biocompatibility enhancement technologies for implantable medical devices Proprietary technologies and products that improve the biocompatibility of biological and polymeric implantable medical devices, sold to medical device manufacturers and implant developers.
Companies that use Biocompatibility Innovation
Customer profileIdeal customer profiles1 record
Biocompatibility Innovation technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Biocompatibility Innovation partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights2 records
Biocompatibility Innovation competitors and assessment
Company assessmentMarket position
Competitive moat3 records
Key risks5 records
Key highlights4 records
Customer concentration
Biocompatibility Innovation social profiles
Digital presenceBiocompatibility Innovation financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biocompatibility Innovation leadership team
Management profileNumber of profiles
Profiles1 record
Biocompatibility Innovation funding detail
Funding detailFunding overview
Funding rounds1 record
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biocompatibility Innovation M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biocompatibility Innovation
What does Biocompatibility Innovation do?
Biocompatibility Innovation develops technologies and products that improve the biocompatibility of biological and polymeric implantable medical devices. The company focuses on material and surface-level innovations that help medical device manufacturers achieve safer, more compatible implants for clinical use.
When was Biocompatibility Innovation founded?
Biocompatibility Innovation was founded in 2014. It employs 1 to 10 people.
Where is Biocompatibility Innovation based?
Biocompatibility Innovation is headquartered in Este, Italy, in the Europe region.
Does Biocompatibility Innovation have an API?
No public API is recorded for Biocompatibility Innovation.
What industry is Biocompatibility Innovation in?
Biocompatibility Innovation's product category is Medical Device Biocompatibility Technologies. Its primary akta.pro industry code is IMAEAOAL, Biodegradable Medical & Hygiene Materials (absorbables, disposables substrates), with a secondary code of HLAAAGAH, Cartilage, Bone & Musculoskeletal Regeneration. Its NAICS code is 3391 and its SIC code is 3841.